Integrated treatment of patients with nonvalvular atrial fibrillation
CSTR:
Author:
Affiliation:

(Department of Cardiology, Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Taiyuan 030032, China)

Clc Number:

Fund Project:

This work was supported by the Preferred Fund for Science and Technology Activities for Returned Overseas Scholars of Shanxi Province(2017-1389), the Project of Applied Basic Research of Shanxi Province (201801D121202), and the Scientific Research Foundation forReturned Overseas Scholars of Shanxi Province (2020-179).

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    Atrial fibrillation (AF) is the most common type of arrhythmia clinically, and previous AF management has focused on the prevention of AF-related embolism and the control of ventricular rate and rhythm. In recent years, the concept of integrated management of AF is gradually popularized. Integrated management of AF emphasizes the prevention of AF-related embolism and symptom control, as well as the improvement of patients′ quality of life and the treatment of complications at the same time, so as to further improve the prognosis of patients. This article reviews the anticoagulant therapy, symptom management, and control of risk factors in patients with nonvalvular atrial fibrillation.

    Reference
    Related
    Cited by
Get Citation
Related Videos

Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:August 16,2021
  • Revised:
  • Adopted:
  • Online: August 29,2022
  • Published:
Article QR Code